Nikolas Zeh
Boehringer Ingelheim (Germany)(DE)
Publications by Year
Research Areas
Viral Infectious Diseases and Gene Expression in Insects, Monoclonal and Polyclonal Antibodies Research, Protein purification and stability, Virus-based gene therapy research, RNA Interference and Gene Delivery
Most-Cited Works
- → Unraveling what makes a monoclonal antibody difficult‐to‐express: From intracellular accumulation to incomplete folding and degradation via ERAD(2019)50 cited
- → The new frontier in CHO cell line development: From random to targeted transgene integration technologies(2024)33 cited
- → Human CAP cells represent a novel source for functional, miRNA-loaded exosome production(2019)24 cited
- → A blueprint from nature: miRNome comparison of plasma cells and CHO cells to optimize therapeutic antibody production(2021)19 cited
- → Cell line development for continuous high cell density biomanufacturing: Exploiting hypoxia for improved productivity(2021)16 cited
- → Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations(2024)14 cited
- → Unveiling the CHO surfaceome: Identification of cell surface proteins reveals cell aggregation‐relevant mechanisms(2021)13 cited
- → Nature as blueprint: Global phenotype engineering of CHO production cells based on a multi-omics comparison with plasma cells(2024)10 cited
- → Loss of a newly discovered microRNA in Chinese hamster ovary cells leads to upregulation of N‐glycolylneuraminic acid sialylation on monoclonal antibodies(2021)9 cited
- → Life at the periphery: what makes CHO cells survival talents(2022)7 cited